{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:26:33Z","timestamp":1790767593585,"version":"4.1.0"},"reference-count":176,"publisher":"Wiley","issue":"8","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd014963","type":"journal-article","created":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T04:45:45Z","timestamp":1629089145000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":89,"title":["Systemic corticosteroids for the treatment of COVID-19"],"prefix":"10.1002","volume":"2021","author":[{"given":"Carina","family":"Wagner","sequence":"additional","affiliation":[{"name":"Cochrane Haematology, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf; Faculty of Medicine and University Hospital Cologne, University of Cologne; Cologne Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirko","family":"Griesel","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology and Intensive Care; University of Leipzig Medical Center; Leipzig Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agata","family":"Mikolajewska","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Respiratory Medicine; Charit\u00e9 - Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin; Berlin Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anika","family":"Mueller","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Intensive Care Medicine, Campus Charit\u00e9 Mitte and Campus Virchow-Klinikum; Charit\u00e9 - Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin, Humboldt-Universit\u00e4t zu Berlin, and Berlin Institute of Health; Berlin Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Nothacker","sequence":"additional","affiliation":[{"name":"AWMF Institute for Medical Knowledge Management; Marburg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karoline","family":"Kley","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology and Intensive Care; University of Leipzig Medical Center; Leipzig Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Inti","family":"Metzendorf","sequence":"additional","affiliation":[{"name":"Cochrane Metabolic and Endocrine Disorders Group; Institute of General Practice, Medical Faculty of the Heinrich-Heine-University D\u00fcsseldorf; D\u00fcsseldorf Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Lena","family":"Fischer","sequence":"additional","affiliation":[{"name":"Department of Anaesthesia and Intensive care; Universit\u00e4tsklinikum Leipzig; 04103 Leipzig Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Kopp","sequence":"additional","affiliation":[{"name":"Cochrane Haematology, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf; Faculty of Medicine and University Hospital Cologne, University of Cologne; Cologne Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Stegemann","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Respiratory Medicine; Charit\u00e9 - Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin; Berlin Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Skoetz","sequence":"additional","affiliation":[{"name":"Cochrane Cancer, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf; Faculty of Medicine and University Hospital Cologne, University of Cologne; Cologne Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Falk","family":"Fichtner","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology and Intensive Care; University of Leipzig Medical Center; Leipzig Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,8,16]]},"reference":[{"issue":"7","key":"10.1002\/14651858.CD014963-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1513\/AnnalsATS.202003-192SD","article-title":"The randomised embedded multifactorial adaptive platform for community-acquired pneumonia (REMAP-CAP) study: rationale and design","volume":"17","author":"Angus","year":"2020","journal-title":"Annals of the American\u00a0Thoracic Society"},{"issue":"13","key":"10.1002\/14651858.CD014963-BIB0002|cit2","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1001\/jama.2020.17022","article-title":"Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: the REMAP-CAP COVID-19 corticosteroid domain randomised clinical trial","volume":"324","author":"Angus","year":"2020","journal-title":"JAMA"},{"issue":"7-8","key":"10.1002\/14651858.CD014963-BIB0003|cit3","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s00508-020-01805-8","article-title":"Methylprednisolone in adults hospitalised with COVID-19 pneumonia: an open-label randomised trial (GLUCOCOVID)","volume":"133","author":"Corral-Gudino","year":"2021","journal-title":"Wiener\u00a0Klinische\u00a0Wochenschrift"},{"key":"10.1002\/14651858.CD014963-BIB0004|cit4","unstructured":"Corral L \u00a0Bahamonde A \u00a0Arnaiz delas Revillas F Gomez-Barquero J Abadia-Otero J Garcia-Ibarbia C GLUCOCOVID: a controlled trial of methylprednisolone in adults hospitalised with COVID-19 pneumonia medRxiv [Preprint] 10.1101\/2020.06.17.20133579"},{"key":"10.1002\/14651858.CD014963-BIB0005|cit5","doi-asserted-by":"crossref","unstructured":"Dequin PF Gouge AL \u00a0Tavernier E \u00a0Giraudeau B \u00a0Zohar S Embedding a COVID-19 group sequential clinical trial within an ongoing trial: lessons from an unusual experience Statistics in Biopharmaceutical Research 2020 1 5 https:\/\/www.embase.com\/search\/results?subaction=viewrecord&id=L2005906375&from=export","DOI":"10.1080\/19466315.2020.1800509"},{"issue":"13","key":"10.1002\/14651858.CD014963-BIB0006|cit6","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1001\/jama.2020.16761","article-title":"Effect of hydrocortisone on 21-day mortality or respiratory support among critically ill patients with COVID-19: a randomised clinical trial","volume":"324","author":"Dequin","year":"2020","journal-title":"JAMA"},{"issue":"6","key":"10.1002\/14651858.CD014963-BIB0007|cit7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1183\/13993003.02808-2020","article-title":"Intravenous methylprednisolone pulse as a treatment for hospitalised severe COVID-19 patients: results from a randomised controlled clinical trial","volume":"56","author":"Edalatifard","year":"2020","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD014963-BIB0008|cit8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21203\/rs.3.rs-66909\/v1","article-title":"Evaluation of the efficacy of methylprednisolone pulse therapy in treatment of COVID-19 adult patients with severe respiratory failure: randomised, clinical trial","volume":"Version 1","year":"2021","journal-title":"Research Square"},{"key":"10.1002\/14651858.CD014963-BIB0009|cit9","doi-asserted-by":"crossref","unstructured":"Horby P Lim WS \u00a0Emberson J \u00a0Mafham M Bell J \u00a0Linsell L Effect of dexamethasone in hospitalised\u00a0patients with COVID-19: preliminary report medRxiv [Preprint] 2020 https:\/\/doi.org\/10.1101\/2020.06.22.20137273","DOI":"10.1101\/2020.06.22.20137273"},{"issue":"8","key":"10.1002\/14651858.CD014963-BIB0010|cit10","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalised\u00a0patients with COVID-19","volume":"384","author":"Horby","year":"2021","journal-title":"New England Journal of\u00a0Medicine"},{"key":"10.1002\/14651858.CD014963-BIB0011|cit11","unstructured":"Oxford University Low-cost dexamethasone reduces death by up to one third in hospitalised patients with severe respiratory complications of COVID-19 University of Oxford 2020"},{"key":"10.1002\/14651858.CD014963-BIB0012|cit12","doi-asserted-by":"publisher","first-page":"173947","DOI":"10.1016\/j.ejphar.2021.173947","article-title":"No clinical benefit of high dose corticosteroid administration in patients with COVID-19: a preliminary report of a randomised clinical trial","volume":"897","author":"Jamaati","year":"2021","journal-title":"European Journal of Pharmacology"},{"issue":"9","key":"10.1002\/14651858.CD014963-BIB0013|cit13","doi-asserted-by":"publisher","first-page":"e373-e81","DOI":"10.1093\/cid\/ciaa1177","article-title":"Methylprednisolone as adjunctive therapy for patients hospitalised\u00a0with COVID-19 (metcovid): a randomised, double-blind, phase IIb, placebo-controlled trial","volume":"72","author":"Jeronimo","year":"2020","journal-title":"Clinical Infectious Diseases"},{"key":"10.1002\/14651858.CD014963-BIB0014|cit14","doi-asserted-by":"crossref","unstructured":"Methylprednisolone or dexamethasone, which one is the superior corticosteroid in the treatment of hospitalised\u00a0COVID-19 Patients: a\u00a0triple-blinded randomised controlled trial Research Square (Preprint) https:\/\/doi.org\/10.21203\/rs.3.rs-148529\/v1","DOI":"10.21203\/rs.3.rs-148529\/v1"},{"issue":"2","key":"10.1002\/14651858.CD014963-BIB0015|cit15","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1159\/000512063","article-title":"Early use of corticosteroid may prolong SARS-CoV-2 shedding in non-intensive care unit patients with COVID-19 pneumonia: a multicenter, single-blind, randomised control trial","volume":"100","author":"Tang","year":"2021","journal-title":"Respiration"},{"key":"10.1002\/14651858.CD014963-BIB0016|cit16","doi-asserted-by":"crossref","unstructured":"Tomazini BM \u00a0Maia IS \u00a0Bueno FR Silva Mvao Baldassare FP Costa EL \u00a0Moura RA COVID-19-associated ARDS treated with DEXamethasone (CoDEX): study design and rationale for a randomised trial medRxiv [Preprint] 2020 https:\/\/doi.org\/10.1101\/2020.06.24.20139303","DOI":"10.5935\/0103-507X.20200063"},{"issue":"3","key":"10.1002\/14651858.CD014963-BIB0017|cit17","doi-asserted-by":"publisher","first-page":"354","DOI":"10.5935\/0103-507X.20200063","article-title":"COVID-19-associated ARDS treated with dexamethasone (CoDEX): study design and rationale for a randomised trial","volume":"32","author":"Tomazini","year":"2020","journal-title":"Revista Brasileira de Terapia Intensiva"},{"issue":"13","key":"10.1002\/14651858.CD014963-BIB0018|cit18","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1001\/jama.2020.17021","article-title":"Effect of dexamethasone on days alive and ventilator-free in patients with moderate or severe acute respiratory distress syndrome and COVID-19: the CoDEX randomised clinical trial","volume":"324","author":"Tomazini","year":"2020","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD014963-BIB0019|cit19","unstructured":"Clinical trial to evaluate methylprednisolone pulses and tacrolimus in hospitalized patients with severe pneumonia secondary to COVID-19 (tacrovid) www.clinicaltrialsregister.eu\/ctr-search\/search?query=eudract_number:2020-001445-39"},{"key":"10.1002\/14651858.CD014963-BIB0020|cit20","unstructured":"TACTIC-COVID www.clinicaltrialsregister.eu\/ctr-search\/search?query=2020-001616-18"},{"key":"10.1002\/14651858.CD014963-BIB0021|cit21","unstructured":"Treatment with inhaled corticoids in patients with COVID-19 and pneumonia www.who.int\/trialsearch\/Trial2.aspx?TrialID=EUCTR2020-001616-18-ES"},{"key":"10.1002\/14651858.CD014963-BIB0022|cit22","unstructured":"Use of inhaled corticosteroids as treatment of early COVID-19 infection to prevent clinical deterioration and hospitalisation www.clinicaltrialsregister.eu\/ctr-search\/trial\/2020-001889-10\/GB"},{"issue":"1","key":"10.1002\/14651858.CD014963-BIB0023|cit23","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1186\/s13063-020-04499-5","article-title":"Letter to the editor: efficacy of different methods of combination regimen administrations including dexamethasone, intravenous immunoglobulin, and interferon-beta to treat critically ill COVID-19 patients: a structured summary of a study protocol for a randomized controlled trial","volume":"21","year":"2020","journal-title":"Trials"},{"key":"10.1002\/14651858.CD014963-BIB0024|cit24","unstructured":"The effect of selenium, vitamin C and methylprednisolone combination on mortality and morbidity of COVID-19 patients en.irct.ir\/trial\/49508"},{"key":"10.1002\/14651858.CD014963-BIB0025|cit25","unstructured":"Effect of corton on olfactory dysfunction in COVID-19 patients en.irct.ir\/trial\/48379"},{"key":"10.1002\/14651858.CD014963-BIB0026|cit26","unstructured":"PRINCIPLE: a trial evaluating treatments for suspected COVID-19 in people aged 50 years and above with pre-existing conditions and those aged 65 years and above www.isrctn.com\/ISRCTN86534580"},{"key":"10.1002\/14651858.CD014963-BIB0027|cit27","unstructured":"Clinical trial to evaluate methylprednisolone pulses and tacrolimus in patients with COVID-19 lung injury clinicaltrials.gov\/show\/NCT04341038"},{"issue":"100716","key":"10.1002\/14651858.CD014963-BIB0028|cit28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.conctc.2021.100716","article-title":"Pragmatic, open-label, single-center, randomized, phase II clinical trial to evaluate the efficacy and safety of methylprednisolone pulses and tacrolimus in patients with severe pneumonia secondary to COVID-19: the TACROVID trial protocol","volume":"21","year":"2021","journal-title":"medRxiv [Preprint]"},{"key":"10.1002\/14651858.CD014963-BIB0029|cit29","unstructured":"Inhaled corticosteroid treatment of COVID-19 patients with pneumonia clinicaltrials.gov\/show\/NCT04355637"},{"key":"10.1002\/14651858.CD014963-BIB0030|cit30","unstructured":"Efficacy and safety of corticosteroids in oxygen-dependent patients with COVID-19 pneumonia clinicaltrials.gov\/show\/NCT04359511"},{"issue":"666","key":"10.1002\/14651858.CD014963-BIB0031|cit31","first-page":"1","article-title":"Efficacy of local budesonide therapy in the management of persistent hyposmia in COVID-19 patients without signs of severity: a structured summary of a study protocol for a randomised controlled trial","volume":"21","author":"Daval","year":"2020","journal-title":"Trials"},{"key":"10.1002\/14651858.CD014963-BIB0032|cit32","unstructured":"Trial evaluating the efficacy of local budesonide\u00a0therapy in the management of hyposmia in COVID-19 patients without signs of severity clinicaltrials.gov\/show\/NCT04361474"},{"key":"10.1002\/14651858.CD014963-BIB0033|cit33","unstructured":"Inhalation of ciclesonide for patients with COVID-19: a randomised open treatment study (HALT COVID-19) clinicaltrials.gov\/show\/NCT04381364"},{"issue":"11","key":"10.1002\/14651858.CD014963-BIB0034|cit34","doi-asserted-by":"publisher","first-page":"e0280","DOI":"10.1097\/CCE.0000000000000280","article-title":"Intravenous immunoglobulin plus methylprednisolone mitigate respiratory morbidity in coronavirus disease 2019","volume":"2","author":"Sakoulas","year":"2020","journal-title":"Critical Care Explorations"},{"key":"10.1002\/14651858.CD014963-BIB0035|cit35","doi-asserted-by":"crossref","unstructured":"Langford B Mahdi M Mwasuku C Inhaled budesonide in the treatment of early COVID-19 illness: a randomised controlled trial medRxiv [Preprint] https:\/\/doi.org\/10.1101\/2021.02.04.21251134","DOI":"10.1101\/2021.02.04.21251134"},{"key":"10.1002\/14651858.CD014963-BIB0036|cit36","doi-asserted-by":"crossref","unstructured":"Riffat M Fridoon A Ahad Q Muhammad AR Syed AG Muhammad AT Aprepitant as a combinant with dexamethasone reduces the inflammation via neurokinin 1 receptor antagonism in severe to critical COVID-19 patients and potentiates respiratory recovery: a novel therapeutic approach medRxiv [Preprint] https:\/\/doi.org\/10.1101\/2020.08.01.20166678","DOI":"10.1101\/2020.08.01.20166678"},{"issue":"2","key":"10.1002\/14651858.CD014963-BIB0037|cit37","first-page":"1","article-title":"Corticosteroid nasal spray for recovery of smell sensation in COVID-19 patients: a randomised controlled trial","volume":"42","author":"Elawady\u00a0","year":"2021","journal-title":"American Journal of Otolaryngology"},{"key":"10.1002\/14651858.CD014963-BIB0038|cit38","unstructured":"Oral prednisone regimens to optimise the therapeutic strategy in patients with organising\u00a0pneumonia post-COVID-19 clinicaltrials.gov\/show\/NCT04534478"},{"key":"10.1002\/14651858.CD014963-BIB0039|cit39","unstructured":"Short term low dose corticosteroids for management of post COVID19 pulmonary fibrosis clinicaltrials.gov\/show\/NCT04551781"},{"key":"10.1002\/14651858.CD014963-BIB0040|cit40","unstructured":"Study to evaluate the efficacy and safety of EG-HPCP-03a compared to DEX in patients with COVID-19 pneumonia clinicaltrials.gov\/show\/NCT04561180"},{"key":"10.1002\/14651858.CD014963-BIB0041|cit41","unstructured":"Effect of nasal steroid in the treatment of anosmia due to COVID-19 disease clinicaltrials.gov\/ct2\/show\/NCT04569825"},{"key":"10.1002\/14651858.CD014963-BIB0042|cit42","unstructured":"Adaptive COVID-19 treatment trial 4 (ACTT-4) clinicaltrials.gov\/show\/NCT04640168"},{"key":"10.1002\/14651858.CD014963-BIB0043|cit43","unstructured":"Comparison of two corticosteroid regimens for post-COVID diffuse lung disease clinicaltrials.gov\/show\/NCT04657484"},{"key":"10.1002\/14651858.CD014963-BIB0044|cit44","unstructured":"Spironolactone and dexamethasone in patients hospitalised\u00a0with COVID-19 (SPIDEX-II) clinicaltrials.gov\/show\/NCT04826822"},{"key":"10.1002\/14651858.CD014963-BIB0045|cit45","unstructured":"Efficacy and safety of corticoids in patients with adult respiratory distress syndrome (ARDS) secondary to coronavirus infection www.clinicaltrialsregister.eu\/ctr-search\/search?query=eudract_number:2020-001307-16"},{"key":"10.1002\/14651858.CD014963-BIB0046|cit46","unstructured":"Dexamethasone associated with hydroxychloroquine vs. hydroxychloroquine alone for the early treatment of severe ARDS caused by COVID-19: a randomised controlled trial www.clinicaltrialsregister.eu\/ctr-search\/search?query=eudract_number:2020-001333-13"},{"key":"10.1002\/14651858.CD014963-BIB0047|cit47","unstructured":"Corticoids in COVID-19 viral pneumonia in infection with SARS-CoV-2 (translation by the review authors) www.clinicaltrialsregister.eu\/ctr-search\/search?query=eudract_number:2020-001553-48"},{"key":"10.1002\/14651858.CD014963-BIB0048|cit48","unstructured":"Effect of prednisolone on treatment of COVID-19 irct.ir\/trial\/46975"},{"key":"10.1002\/14651858.CD014963-BIB0049|cit49","unstructured":"Corticosteroids in COVID-19 irct.ir\/trial\/51163"},{"key":"10.1002\/14651858.CD014963-BIB0050|cit50","unstructured":"Evaluating the effect of intravenous hydrocortisone, methylprednisolone, and dexamethasone in treatment of patients with moderate to severe acute respiratory distress syndrome caused by COVID-19 irct.ir\/trial\/48043"},{"key":"10.1002\/14651858.CD014963-BIB0051|cit51","unstructured":"The effect of dexamethasone in the treatment of high-risk COVID-19 patients irct.ir\/trial\/48310"},{"key":"10.1002\/14651858.CD014963-BIB0052|cit52","unstructured":"Evaluation of efficacy and safety of low dose corticosteroid with severe pneumonia COVID-19 irct.ir\/trial\/49116"},{"key":"10.1002\/14651858.CD014963-BIB0053|cit53","unstructured":"Effect of dexamethasone on treatment of COVID-19 www.irct.ir\/trial\/51736"},{"key":"10.1002\/14651858.CD014963-BIB0054|cit54","unstructured":"Comparing two medications (dexamethasone and methylprednisolone high dose) for the treatment of pneumonia in patients with COVID-19 www.isrctn.com\/ISRCTN33037282"},{"key":"10.1002\/14651858.CD014963-BIB0055|cit55","unstructured":"Munch MW Meyhoff TS Helleberg M Granholm A Hjorts\u00f8 CJ Low-dose hydrocortisone in patients with COVID-19 and severe hypoxia: the COVID STEROID randomised, placebo-controlled trial Acta Anaesthesiologica Scandinavica 10.1111\/aas.13941"},{"key":"10.1002\/14651858.CD014963-BIB0056|cit56","unstructured":"Hydrocortisone for COVID-19 and severe hypoxia clinicaltrials.gov\/show\/NCT04348305"},{"issue":"9","key":"10.1002\/14651858.CD014963-BIB0057|cit57","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1111\/aas.13673","article-title":"Low-dose hydrocortisone in patients with COVID-19 and severe hypoxia (COVID STEROID) trial-protocol and statistical analysis plan","volume":"64","author":"Petersen","year":"2020","journal-title":"Acta Anaesthesiologica Scandinavica"},{"key":"10.1002\/14651858.CD014963-BIB0058|cit58","unstructured":"Steroid dosing by biomarker guided titration in critically ill patients with pneumonia clinicaltrials.gov\/show\/NCT03852537"},{"key":"10.1002\/14651858.CD014963-BIB0059|cit59","unstructured":"Glucocorticoid therapy for novel coronavirus critically ill patients with severe acute respiratory failure www.clinicaltrials.gov\/ct2\/show\/NCT04244591"},{"key":"10.1002\/14651858.CD014963-BIB0060|cit60","unstructured":"Efficacy of dexamethasone treatment for patients with ARDS caused by COVID-19 clinicaltrials.gov\/ct2\/show\/NCT04325061"},{"key":"10.1002\/14651858.CD014963-BIB0061|cit61","unstructured":"COVID-19 primary care platform for early treatment and recovery (COPPER) study clinicaltrials.gov\/show\/NCT04746430"},{"key":"10.1002\/14651858.CD014963-BIB0062|cit62","unstructured":"Tocilizumab\u00a0versus dexamethasone in severe COVID19 cases clinicaltrials.gov\/show\/NCT04519385"},{"issue":"8816","key":"10.1002\/14651858.CD014963-BIB0063|cit63","first-page":"1","article-title":"Short term survival of critically ill COVID-19 Egyptian patients on assisted ventilation treated by either dexamethasone or tocilizumab","volume":"11","author":"Rashad","year":"2021","journal-title":"Scientific Reports"},{"key":"10.1002\/14651858.CD014963-BIB0064|cit64","doi-asserted-by":"crossref","unstructured":"Zhou YH Lu YQ Sun F Yang S Harypursat V Effectiveness of glucocorticoid therapy in patients with severe novel coronavirus pneumonia: protocol of a randomised controlled trial Chinese Medical Journal 2020 133 9 1080 6 10.1097\/CM9.0000000000000791","DOI":"10.1097\/CM9.0000000000000791"},{"key":"10.1002\/14651858.CD014963-BIB0065|cit65","unstructured":"A randomised, open-label study to evaluate the efficacy and safety of low-dose corticosteroids in hospitalised patients with novel coronavirus pneumonia (COVID-19) www.chictr.org.cn\/showprojen.aspx?proj=49086"},{"key":"10.1002\/14651858.CD014963-BIB0066|cit66","unstructured":"The clinical value of corticosteroid therapy timing in the treatment of novel coronavirus pneumonia (COVID-19): a prospective randomised controlled trial www.chictr.org.cn\/showprojen.aspx?proj=50453"},{"key":"10.1002\/14651858.CD014963-BIB0067|cit67","unstructured":"A clinical trial to study the effects of two drugs methylprednisolone and dexamethasone in patients with severe COVID-19 www.ctri.nic.in\/Clinicaltrials\/pmaindet2.php?trialid=45638"},{"key":"10.1002\/14651858.CD014963-BIB0068|cit68","unstructured":"Higher vs. lower doses of dexamethasone in patients with COVID-19 and severe hypoxia ctri.nic.in\/Clinicaltrials\/showallp.php?mid1=46442&EncHid=&userName=28731"},{"key":"10.1002\/14651858.CD014963-BIB0069|cit69","unstructured":"Higher vs. lower doses of steroids in patients with COVID-19 www.who.int\/trialsearch\/Trial2.aspx?TrialID=CTRI\/2020\/10\/028731"},{"key":"10.1002\/14651858.CD014963-BIB0070|cit70","unstructured":"Comparing the effectiveness of dexamethasone versus methylprednisolone in patients with moderate COVID 19 - a randomised controlled trial ctri.nic.in\/Clinicaltrials\/showallp.php?mid1=49273&EncHid=&userName=029894"},{"key":"10.1002\/14651858.CD014963-BIB0071|cit71","unstructured":"A study to compare the effectiveness of two drugs, dexamethasone versus methylprednisolone in the treatment of moderate Covid 19 patients www.who.int\/trialsearch\/Trial2.aspx?TrialID=CTRI\/2020\/12\/029894"},{"key":"10.1002\/14651858.CD014963-BIB0072|cit72","unstructured":"Comparison of different steroid regimes in critically ill adult patients of COVID-19 www.who.int\/trialsearch\/Trial2.aspx?TrialID=CTRI\/2020\/12\/030143"},{"key":"10.1002\/14651858.CD014963-BIB0073|cit73","unstructured":"Evaluation of different steroid regimes in critically ill adult patients of COVID-19 admitted to intensive care units ctri.nic.in\/Clinicaltrials\/showallp.php?mid1=50886&EncHid=&userName=30143"},{"key":"10.1002\/14651858.CD014963-BIB0074|cit74","unstructured":"Efficacy and safety of siltuximab vs. corticosteroids in hospitalized patients with COVID-19 pneumonia www.clinicaltrialsregister.eu\/ctr-search\/search?query=eudract_number:2020-001413-20"},{"key":"10.1002\/14651858.CD014963-BIB0075|cit75","unstructured":"Dexamethasone and oxygen support strategies in ICU patients with COVID-19 pneumonia www.clinicaltrialsregister.eu\/ctr-search\/search?query=eudract_number:2020-001457-43"},{"key":"10.1002\/14651858.CD014963-BIB0076|cit76","unstructured":"Outpatient treatment of COVID-19 with early pulmonary corticosteroids as an opportunity to modify the course of the disease www.clinicaltrialsregister.eu\/ctr-search\/search?query=eudract_number:2020-001622-64"},{"issue":"632","key":"10.1002\/14651858.CD014963-BIB0077|cit77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13063-020-04575-w","article-title":"Outpatient treatment of COVID-19 with steroids in the phase of mild pneumonia without the need for admission as an opportunity to modify the course of the disease: a structured summary of a randomised controlled trial","volume":"21","author":"Saiz-Rodr\u00edguez","year":"2020","journal-title":"Trials"},{"key":"10.1002\/14651858.CD014963-BIB0078|cit78","unstructured":"Phase III randomised, unicentric open, controlled clinical trial to demonstrate the effectiveness of tocilizumab against\u00a0 systemic corticotherapy in patients entered by COVID-19 with bilateral pneumonia and bad evolution www.clinicaltrialsregister.eu\/ctr-search\/trial\/2020-001707-16\/ES"},{"issue":"1","key":"10.1002\/14651858.CD014963-BIB0079|cit79","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1186\/s13063-020-04645-z","article-title":"Multi-centre, three arm, randomised controlled trial on the use of methylprednisolone and unfractionated heparin in critically ill ventilated patients with pneumonia from SARS-CoV-2 infection: a structured summary of a study protocol for a randomised controlled trial","volume":"21","author":"Busani","year":"2020","journal-title":"Trials"},{"key":"10.1002\/14651858.CD014963-BIB0080|cit80","unstructured":"Steroids and unfractionated heparin in critically-ill patients with pneumonia from COVID-19 infection. A multicenter, interventional, randomised, three arms study design www.clinicaltrialsregister.eu\/ctr-search\/search?query=eudract_number:2020-001921-30"},{"key":"10.1002\/14651858.CD014963-BIB0081|cit81","unstructured":"Efficacy of the early use of corticotherapy in CoV-2 infection to prevent the progression of acute respiratory distress syndrome (ARDS) www.clinicaltrialsregister.eu\/ctr-search\/search?query=eudract_number:2020-002186-34"},{"key":"10.1002\/14651858.CD014963-BIB0082|cit82","unstructured":"Higher vs. lower doses of dexamethasone in patients with COVID-19 and severe oxygen deficiency: the COVID STEROID 2 trial www.clinicaltrialsregister.eu\/ctr-search\/search?query=eudract_number:2020-003363-25"},{"key":"10.1002\/14651858.CD014963-BIB0083|cit83","unstructured":"Evaluation of the efficacy of high doses of methylprednisolone in SARS-CoV2 pneumonia patients www.clinicaltrialsregister.eu\/ctr-search\/trial\/2020-004323-16\/IT"},{"key":"10.1002\/14651858.CD014963-BIB0084|cit84","unstructured":"Efficacy and safety of siltuximab vs. corticosteroids in hospitalised\u00a0patients with COVID19 pneumonia clinicaltrials.gov\/show\/NCT04329650"},{"key":"10.1002\/14651858.CD014963-BIB0085|cit85","unstructured":"Dexamethasone and oxygen support strategies in ICU patients with COVID-19 pneumonia clinicaltrials.gov\/show\/NCT04344730"},{"key":"10.1002\/14651858.CD014963-BIB0086|cit86","unstructured":"Study to evaluate the efficacy and safety of tocilizumab\u00a0versus corticosteroids in hospitalised COVID-19 patients with high risk of progression clinicaltrials.gov\/show\/NCT04345445"},{"key":"10.1002\/14651858.CD014963-BIB0087|cit87","unstructured":"Dexamethasone treatment for severe acute respiratory distress syndrome clinicaltrials.gov\/show\/NCT04347980"},{"key":"10.1002\/14651858.CD014963-BIB0088|cit88","unstructured":"Tocilizumab\u00a0versus methylprednisolone in the cytokine release syndrome of patients with COVID-19 clinicaltrials.gov\/show\/NCT04377503"},{"issue":"1","key":"10.1002\/14651858.CD014963-BIB0089|cit89","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1186\/s13063-020-04646-y","article-title":"High dose dexamethasone treatment for acute respiratory distress syndrome secondary to COVID-19: a structured summary of a study protocol for a randomised controlled trial","volume":"21","year":"2020","journal-title":"Trials"},{"key":"10.1002\/14651858.CD014963-BIB0090|cit90","unstructured":"Dexamethasone for COVID-19 related ARDS: a multicenter, randomised clinical trial clinicaltrials.gov\/show\/NCT04395105"},{"issue":"1","key":"10.1002\/14651858.CD014963-BIB0091|cit91","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13063-020-04999-4","article-title":"Treatment of COVID-19 pneumonia with glucocorticoids (CORTIVID): a structured summary of a study protocol for a randomised controlled trial","volume":"22","year":"2021","journal-title":"Trials"},{"key":"10.1002\/14651858.CD014963-BIB0092|cit92","unstructured":"Glucocorticoids in COVID-19 (CORTIVID) clinicaltrials.gov\/show\/NCT04438980"},{"key":"10.1002\/14651858.CD014963-BIB0093|cit93","unstructured":"Early use of corticosteroids in hospitalised patients with moderate COVID19 pneumonia clinicaltrials.gov\/show\/NCT04451174"},{"issue":"1","key":"10.1002\/14651858.CD014963-BIB0094|cit94","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s13063-021-05046-6.","article-title":"Early use of corticosteroids in non-critical patients with COVID-19 pneumonia (PREDCOVID): a structured summary of a study protocol for a randomised controlled trial","volume":"22","author":"Palma","year":"2021","journal-title":"Trials"},{"key":"10.1002\/14651858.CD014963-BIB0095|cit95","unstructured":"NA-831, atazanavir and dexamethasone in the treatment of SARSCov-2 infection (NATADEX) clinicaltrials.gov\/show\/NCT04452565"},{"key":"10.1002\/14651858.CD014963-BIB0096|cit96","unstructured":"Efficacy assessment of methylprednisolone and heparin in patients with COVID-19 pneumonia clinicaltrials.gov\/show\/NCT04485429"},{"key":"10.1002\/14651858.CD014963-BIB0097|cit97","unstructured":"Dexamethasone versus methylprednisolone for the treatment of patients with ARDS caused by COVID-19 clinicaltrials.gov\/show\/NCT04499313"},{"key":"10.1002\/14651858.CD014963-BIB0098|cit98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/aas.13795","article-title":"Higher vs. lower doses of dexamethasone in patients with COVID-19 and severe hypoxia (COVID STEROID 2) trial: protocol and statistical analysis plan","volume":"00","author":"Munch","year":"2021","journal-title":"Acta Anaesthesiologica Scandinavica"},{"key":"10.1002\/14651858.CD014963-BIB0099|cit99","unstructured":"Higher vs. lower doses of dexamethasone for COVID-19 and severe hypoxia clinicaltrials.gov\/show\/NCT04509973"},{"key":"10.1002\/14651858.CD014963-BIB0100|cit100","unstructured":"Randomised clinical trial of nasal dexamethasone as an adjuvant in patients with COVID-19 clinicaltrials.gov\/show\/NCT04513184"},{"key":"10.1002\/14651858.CD014963-BIB0101|cit101","unstructured":"Anosmia and \/ or ageusia and early corticosteroid use clinicaltrials.gov\/show\/NCT04528329"},{"key":"10.1002\/14651858.CD014963-BIB0102|cit102","unstructured":"Steroids and unfractionated heparin in critically ill patients with pneumonia from COVID-19 infection clinicaltrials.gov\/show\/NCT04528888 https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/trial\/2020-001921-30\/IT https:\/\/clinicaltrials.gov\/ct2\/show\/study\/NCT04528888"},{"key":"10.1002\/14651858.CD014963-BIB0103|cit103","unstructured":"Timing of corticosteroids in COVID-19 clinicaltrials.gov\/show\/NCT04530409"},{"key":"10.1002\/14651858.CD014963-BIB0104|cit104","unstructured":"Efficacy of dexamethasone in patients with acute hypoxemic\u00a0respiratory failure caused by infections clinicaltrials.gov\/show\/NCT04545242"},{"key":"10.1002\/14651858.CD014963-BIB0105|cit105","unstructured":"Methylprednisolone vs. dexamethasone in COVID-19 pneumonia (MEDEAS RCT) clinicaltrials.gov\/show\/NCT04636671"},{"key":"10.1002\/14651858.CD014963-BIB0106|cit106","unstructured":"Effect of two different doses of dexamethasone in patients with ARDS and COVID-19 clinicaltrials.gov\/show\/NCT04663555"},{"key":"10.1002\/14651858.CD014963-BIB0107|cit107","unstructured":"Evaluation of the efficacy of high doses of methylprednisolone in SARS-CoV2 ( COVID-19) pneumonia patients clinicaltrials.gov\/show\/NCT04673162"},{"key":"10.1002\/14651858.CD014963-BIB0108|cit108","unstructured":"Dexamethasone for COVID-19 clinicaltrials.gov\/show\/NCT04707534"},{"key":"10.1002\/14651858.CD014963-BIB0109|cit109","unstructured":"Low or high dose of dexamethasone in patients with respiratory failure by COVID-19 clinicaltrials.gov\/ct2\/show\/record\/NCT04726098"},{"key":"10.1002\/14651858.CD014963-BIB0110|cit110","unstructured":"Comparison between prednisolone and dexamethasone on mortality in patients on oxygen therapy, with COVID-19 clinicaltrials.gov\/ct2\/show\/NCT04765371"},{"key":"10.1002\/14651858.CD014963-BIB0111|cit111","unstructured":"Glucocorticoid therapy in coronavirus disease COVID-19 patients clinicaltrials.gov\/show\/NCT04780581"},{"key":"10.1002\/14651858.CD014963-BIB0112|cit112","unstructured":"Corticosteroids for COVID-19 clinicaltrials.gov\/show\/NCT04795583"},{"key":"10.1002\/14651858.CD014963-BIB0113|cit113","unstructured":"Randomised open investigation determining steroid dose clinicaltrials.gov\/show\/NCT04834375"},{"key":"10.1002\/14651858.CD014963-BIB0114|cit114","unstructured":"Dexamethasone early administration in hospitalised\u00a0patients with COVID-19 pneumonia clinicaltrials.gov\/show\/NCT04836780"},{"issue":"3","key":"10.1002\/14651858.CD014963-BIB0115|cit115","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/sj.bjp.0706736","article-title":"How corticosteroids control inflammation: quintiles prize lecture","volume":"148","author":"Barnes","year":"2005","journal-title":"British Journal of Pharmacology"},{"key":"10.1002\/14651858.CD014963-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/B0-12-341103-3\/00122-4","volume-title":"Encyclopedia of Hormones","volume":"-","author":"Bourdeau","year":"2003"},{"key":"10.1002\/14651858.CD014963-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/1471-2288-11-144","article-title":"How to handle mortality when investigating length of hospital stay and time to clinical stability","volume":"11","author":"Brock","year":"2011","journal-title":"BMC Medical Research Methodology"},{"issue":"9","key":"10.1002\/14651858.CD014963-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"e1003346","DOI":"10.1371\/journal.pmed.1003346","article-title":"Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: a living systematic review and meta-analysis","volume":"17","author":"Buitrago-Garcia","year":"2020","journal-title":"PLoS Medicine"},{"key":"10.1002\/14651858.CD014963-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"521-37","DOI":"10.1007\/s00134-021-06394-2","article-title":"Corticosteroids in\u00a0COVID-19 and\u00a0non-COVID-19 ARDS: a systematic review and\u00a0meta-analysis","volume":"47","author":"Chaudhuri","year":"2021","journal-title":"Intensive Care Medicine"},{"key":"10.1002\/14651858.CD014963-BIB0120|cit120","unstructured":"Competing Risk Analysis Columbia University Mailman School of Public Health Website. Available from www.publichealth.columbia.edu\/research\/population-health-methods\/competing-risk-analysis https:\/\/www.publichealth.columbia.edu\/research\/population-health-methods\/competing-risk-analysis"},{"key":"10.1002\/14651858.CD014963-BIB0121|cit121","unstructured":"Core outcome set developers\u2019 response to COVID-19 www.comet-initiative.org\/Studies\/Details\/1538"},{"key":"10.1002\/14651858.CD014963-BIB0122|cit122","unstructured":"Deeks JJ Higgins JP Altman DG Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Version 6.2 (updated February 2021). Cochrane, 2021 Available from training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD014963-BIB0123|cit123","unstructured":"EndNote X9 Clarivate 2020"},{"key":"10.1002\/14651858.CD014963-BIB0124|cit124","unstructured":"McMaster University (developed by Evidence Prime) GRADEpro GDT"},{"key":"10.1002\/14651858.CD014963-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD014963-BIB0126|cit126","unstructured":"Higgins JP Savovic J Page MJ Sterne JA Revised Cochrane risk-of-bias tool for randomized trials (RoB 2) www.riskofbias.info\/welcome\/rob-2-0-tool\/current-version-of-rob-2"},{"key":"10.1002\/14651858.CD014963-BIB0127|cit127","doi-asserted-by":"crossref","unstructured":"Higgins JP Thomas J Chandler J Cumpston M Li T Page MJ Cochrane Handbook for Systematic Reviews of Interventions\u00a0version version 6.2\u00a0(updated February\u00a02021). Cochrane, 2021 Available from: training.cochrane.org\/handbook 2020","DOI":"10.1002\/9781119536604"},{"key":"10.1002\/14651858.CD014963-BIB0128|cit128","unstructured":"Higgins JP Savovic\u0301 J Page MJ Elbers RG Sterne JA Chapter 8: Assessing risk of bias in a randomized trial. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021 Available from training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD014963-BIB0129|cit129","unstructured":"Higgins JP Li T Deeks JJ Chapter 6: Choosing effect measures and computing estimates of effect. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021 Available from training.cochrane.org\/handbook"},{"issue":"10223","key":"10.1002\/14651858.CD014963-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD014963-BIB0131|cit131","unstructured":"Johns Hopkins University Mortality analyses coronavirus.jhu.edu\/data\/mortality"},{"issue":"1","key":"10.1002\/14651858.CD014963-BIB0132|cit132","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013825","article-title":"SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19","author":"Hirsch","year":"2021","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9","key":"10.1002\/14651858.CD014963-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"577-82","DOI":"10.7326\/M20-0504","article-title":"The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application","volume":"172","author":"Lauer","year":"2020","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD014963-BIB0134|cit134","unstructured":"Li T Higgins JP Chapter 5: Collecting data. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Version 6.1 (updated February 2021). Cochrane, 2021 Available from training.cochrane.org\/handbook"},{"issue":"3","key":"10.1002\/14651858.CD014963-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1470-2045(20)30096-6","article-title":"Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China","volume":"21","author":"Liang","year":"2020","journal-title":"Lancet Oncology"},{"key":"10.1002\/14651858.CD014963-BIB0136|cit136","unstructured":"Living Evidence Network Guidance for the production and publication of Cochrane living systematic reviews: Cochrane Reviews in living mode (Version December 2019) Available from community.cochrane.org\/review-production\/production-resources\/living-systematic-reviews"},{"issue":"8","key":"10.1002\/14651858.CD014963-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"e192","DOI":"10.1016\/S1473-3099(20)30483-7","article-title":"A minimal common outcome measure set for COVID-19 clinical research","volume":"20","author":"Marshall","year":"2020","journal-title":"Lancet Infectious Diseases"},{"key":"10.1002\/14651858.CD014963-BIB0138|cit138","unstructured":"Microsoft Excel Microsoft Corporation 2018"},{"issue":"10","key":"10.1002\/14651858.CD014963-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"62","author":"Moher","year":"2009","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD014963-BIB0140|cit140","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jclinepi.2020.04.025","article-title":"An overview of platform trials with a checklist for clinical readers","volume":"125","author":"Park","year":"2020","journal-title":"Journal of Clinical Epidemiology"},{"issue":"24","key":"10.1002\/14651858.CD014963-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","article-title":"Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints","volume":"17","author":"Parmar","year":"1998","journal-title":"Statistics in Medicine"},{"issue":"2","key":"10.1002\/14651858.CD014963-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1053\/j.jvca.2020.11.057","article-title":"Corticosteroids for patients with coronavirus disease 2019 (COVID-19) with different disease severity: a meta-analysis of randomized clinical trials","volume":"35","author":"Pasin","year":"2021","journal-title":"Journal of Cardiothoracic and Vascular Anesthesia"},{"key":"10.1002\/14651858.CD014963-BIB0143|cit143","doi-asserted-by":"crossref","unstructured":"Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review Cochrane Database of Systematic Reviews 2021 5 10.1002\/14651858.CD013600.pub4","DOI":"10.1002\/14651858.CD013600.pub4"},{"issue":"4","key":"10.1002\/14651858.CD014963-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"222-4","DOI":"10.4103\/2229-3485.167092","article-title":"Common pitfalls in statistical analysis: odds versus risk","volume":"6","author":"Ranganathan","year":"2015","journal-title":"Perspectives in Clinical Research"},{"key":"10.1002\/14651858.CD014963-BIB0145|cit145","unstructured":"The Cochrane Collaboration Review Manager Web (RevMan Web) 2019"},{"issue":"16","key":"10.1002\/14651858.CD014963-BIB0146|cit146","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1056\/NEJMra050541","article-title":"Antiinflammatory action of glucocorticoids - new mechanisms for old drugs","volume":"353","author":"Rhen","year":"2005\u00a0","journal-title":"New England Journal of Medicine"},{"issue":"9","key":"10.1002\/14651858.CD014963-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1097\/CCM.0000000000003262","article-title":"Corticosteroids in sepsis: an updated systematic review and meta-analysis","volume":"46","author":"Rochwerg","year":"2018","journal-title":"Critical Care Medicine"},{"key":"10.1002\/14651858.CD014963-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jclinepi.2019.10.014","article-title":"GRADE guidelines 26: informative statements to communicate the findings of systematic reviews of interventions","volume":"119","author":"Santesso","year":"2020","journal-title":"Journal of Clinical Epidemiology"},{"issue":"6","key":"10.1002\/14651858.CD014963-BIB0149|cit149","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.cell.2020.08.001","article-title":"Severe COVID-19 is marked by a dysregulated myeloid cell compartment","volume":"182","year":"2020","journal-title":"Cell"},{"key":"10.1002\/14651858.CD014963-BIB0150|cit150","unstructured":"Sch\u00fcnemann HJ Higgins JP Vist GE Glasziou P Akl EA Skoetz N Chapter 14: Completing \u2018Summary of findings\u2019 tables and grading the certainty of the evidence. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February 2021). Cochrane, 2021 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD014963-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"m2980","DOI":"10.1136\/bmj.m2980","article-title":"Drug treatments for COVID-19: living systematic review and network meta-analysis","volume":"370","author":"Siemieniuk","year":"2020","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD014963-BIB0152|cit152","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jclinepi.2019.10.015","article-title":"GRADE guidelines 27: how to calculate absolute effects for time-to-event outcomes in summary of findings tables and evidence profiles","volume":"118","author":"Skoetz","year":"2020","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD014963-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"issue":"13","key":"10.1002\/14651858.CD014963-BIB0154|cit154","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1001\/jama.2020.17023","article-title":"Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis","volume":"324","author":"Sterne","year":"2020","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD014963-BIB0155|cit155","first-page":"462","volume-title":"Pharmacology & Physiology in Anesthetic Practice","author":"Stoelting","year":"2006"},{"issue":"7","key":"10.1002\/14651858.CD014963-BIB0156|cit156","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013665","article-title":"Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 disease","author":"Struyf","year":"2020","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD014963-BIB0157|cit157","first-page":"1","article-title":"Clinical and virological characteristics of hospitalised COVID-19 patients in a German tertiary care centre during the first wave of the SARS-CoV-2 pandemic: a prospective observational study","volume":"-","author":"M\u00fchlemann","year":"2021","journal-title":"Infection"},{"key":"10.1002\/14651858.CD014963-BIB0158|cit158","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1745-6215-8-16","article-title":"Practical methods for incorporating summary time-to-event data into meta-analysis","volume":"8","author":"Tierney","year":"2007","journal-title":"Trials"},{"issue":"11","key":"10.1002\/14651858.CD014963-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"1622-35","DOI":"10.1097\/CCM.0000000000004585","article-title":"Core outcomes set for trials in people with coronavirus disease 2019","volume":"48","author":"Tong","year":"2020","journal-title":"Critical Care Medicine"},{"issue":"696","key":"10.1002\/14651858.CD014963-BIB0160|cit160","first-page":"1","article-title":"Corticosteroid use in\u00a0COVID-19 patients: a\u00a0systematic review and\u00a0meta-analysis on\u00a0clinical outcomes","volume":"24","author":"Van Paassen","year":"2020","journal-title":"Critical Care"},{"issue":"3","key":"10.1002\/14651858.CD014963-BIB0161|cit161","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S2213-2600(19)30417-5","article-title":"Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial","volume":"8","year":"2020","journal-title":"Lancet Respiratory Medicine"},{"key":"10.1002\/14651858.CD014963-BIB0162|cit162","unstructured":"World Health Organization Cumulative number of reported probable cases of SARS www.who.int\/csr\/sars\/country\/2003_07_11\/en"},{"key":"10.1002\/14651858.CD014963-BIB0163|cit163","unstructured":"World Health Organization Middle East respiratory syndrome coronavirus (MERS-CoV) www.who.int\/emergencies\/mers-cov\/en"},{"key":"10.1002\/14651858.CD014963-BIB0164|cit164","unstructured":"World Health Organization Report of the WHO-China joint mission on coronavirus disease 2019 (COVID-19) www.who.int\/docs\/default-source\/coronaviruse\/who-china-joint-mission-on-covid-19-final-report"},{"key":"10.1002\/14651858.CD014963-BIB0165|cit165","unstructured":"World Health Organization Estimating mortality from COVID-19 - scientific brief www.who.int\/publications\/i\/item\/WHO-2019-nCoV-Sci-Brief-Mortality-2020.1"},{"key":"10.1002\/14651858.CD014963-BIB0166|cit166","unstructured":"WHO working group on the clinical characterisation and management of COVID-19 infection A minimal common outcome measure set for COVID-19 clinical research Lancet Infectious Diseases 2020 20 8 e192 7"},{"key":"10.1002\/14651858.CD014963-BIB0167|cit167","unstructured":"World Health Organization WHO coronavirus disease (COVID-19) dashboard covid19.who.int"},{"key":"10.1002\/14651858.CD014963-BIB0168|cit168","unstructured":"World Health Organization Weekly epidemiological update - 23 February 2021 www.who.int\/publications\/m\/item\/weekly-epidemiological-update---23-february-2021"},{"key":"10.1002\/14651858.CD014963-BIB0169|cit169","unstructured":"World Health Organization SARS-CoV-2 variants Available from www.who.int\/csr\/don\/31-december-2020-sars-cov2-variants\/en\/"},{"key":"10.1002\/14651858.CD014963-BIB0170|cit170","unstructured":"World Health Organization 2021 COVID-19 Clinical management: living guidance. 6. Who do the recommendations apply to? www.who.int\/publications\/i\/item\/WHO-2019-nCoV-clinical-2021-1 2021 3 14 https:\/\/www.who.int\/publications\/i\/item\/WHO-2019-nCoV-therapeutics-2021.1"},{"key":"10.1002\/14651858.CD014963-BIB0171|cit171","unstructured":"Therapeutics and COVID-19: living guideline. Systemic corticosteroids www.who.int\/publications\/i\/item\/WHO-2019-nCoV-therapeutics-2021.2 3 37 50 https:\/\/www.who.int\/publications\/i\/item\/WHO-2019-nCoV-therapeutics-2021.1"},{"key":"10.1002\/14651858.CD014963-BIB0172|cit172","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","article-title":"Factors associated with COVID-19-related death using OpenSAFELY","volume":"584","author":"Williamson","year":"2020","journal-title":"Nature"},{"key":"10.1002\/14651858.CD014963-BIB0173|cit173","unstructured":"World Bank Country and Lending Groups datahelpdesk.worldbank.org\/knowledgebase\/articles\/906519-world-bank-country-and-lending-groups https:\/\/datahelpdesk.worldbank.org\/knowledgebase\/articles\/906519-world-bank-country-and-lending-groups"},{"issue":"13","key":"10.1002\/14651858.CD014963-BIB0174|cit174","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention","volume":"323","author":"Wu","year":"2020","journal-title":"JAMA"},{"issue":"7","key":"10.1002\/14651858.CD014963-BIB0175|cit175","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1164\/rccm.201810-2050CP","article-title":"Reappraisal of ventilator-free days in critical care research","volume":"200","year":"2019","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD014963-BIB0176|cit176","unstructured":"Wagner C Griesel M Micholajewska A Fichtner F Skoetz N Corticosteroids for the treatment of COVID-19 (part of German Ecosystem CEO-Sys) PROSPERO"}],"updated-by":[{"DOI":"10.1002\/14651858.cd014963.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T00:00:00Z","timestamp":1668643200000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T09:41:08Z","timestamp":1658137268000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD014963"}},"subtitle":[],"editor":[{"name":"Cochrane Haematology Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,8,16]]},"references-count":176,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,8]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd014963","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD014963.pub2","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,16]]}}}